Antiangiogen behandling av öyesykdommer
Engelsk titel: Antiangiogenic treatment of ocular diseases
Läs online
Författare:
Sundlisaeter, Eirik
;
Tvedt, Christine
Email: eirik.sundlisater@rr-research.no
Språk: Nor
Antal referenser: 22
Dokumenttyp:
Artikel
UI-nummer: 19010290
Sammanfattning
Vascular endothelial growth factor is central to the pathogenesis of a number of ocular diseases. Drugs that inhibit vascular endothelial growth factor have opened up new possibilities for the prevention of visual impairment and blindness.